Publikation

Symptom burden in glioblastoma - a prospective pilot study from diagnosis to first progression.

Wissenschaftlicher Artikel/Review - 01.07.2022

Bereiche
PubMed
DOI
Kontakt

Zitation
Roelcke U, Schwyzer L, Zeitlberger A, Hundsberger T. Symptom burden in glioblastoma - a prospective pilot study from diagnosis to first progression. Oncology 2022
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Oncology 2022
Veröffentlichungsdatum
01.07.2022
eISSN (Online)
1423-0232
Kurzbeschreibung/Zielsetzung

The evaluation of symptom burden, performance status and neurological function is still challenging in glioblastoma (GBM) patients. Patients may suffer from a wide spectrum of neurological symptoms like cognitive deficits, aphasia or hemiparesis, which interfere to report to comprehensive questionnaires. However, an integrated and reliable neuro-oncological assessment is key in the clinical management and in the evaluation of treatment benefits for GBM patients.